mTOR-mediated cancer drug resistance suppresses autophagy and generates a druggable metabolic vulnerability
Niklas Gremke(Philipps University of Marburg), Thorsten Stiewe(Philipps University of Marburg)
Cited by 171
Related Papers
Challenging ChatGPT 3.5 in Senology—An Assessment of Concordance with Breast Cancer Tumor Board Decision Making
|Journal of Personalized Medicine|2023|70
Monitoring the dynamics of clonal tumour evolution in vivo using secreted luciferases
|Nature Communications|2014|46
Phosphorylation Control of p53 DNA-Binding Cooperativity Balances Tumorigenesis and Aging
|Cancer Research|2020|30
Positive association between body height and breast cancer prevalence: a retrospective study with 135,741 women in Germany
|Breast Cancer Research and Treatment|2022|19
Mutant p53-ENTPD5 control of the calnexin/calreticulin cycle: a druggable target for inhibiting integrin-α5-driven metastasis
|Journal of Experimental & Clinical Cancer Research|2023|19